On March 28, 2019, the Food and Drug Administration (FDA), in collaboration with the Federal Trade Commission (FTC), issued warning letters to Advanced Spine and Pain, LLC, Nutra Pure, LLC, and PotNetwork Holdings, Inc. The...more
4/22/2019
/ Advertising Substantiation ,
Cannabidiol (CBD) oil ,
Cannabis Products ,
Dietary Supplements ,
FDA Approval ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Federal Trade Commission (FTC) ,
Food and Drug Administration (FDA) ,
Fraudulent Marketing ,
FTC Act ,
Misbranding ,
Product Labels ,
Public Safety ,
Scientific Evidence ,
Warning Letters
The FDA’s concern over the sale of pure or highly concentrated bulk caffeine products recently resulted in warning letters to Liquidcaffeine.com (“Liquidcaffeine”) and Dual Health Body and Mind (“Dual Health”) related to...more
The FDA and FTC jointly issued thirteen (13) warning letters to companies involved in the manufacture, distribution and retail of certain e-liquid products to be used in connection with e-cigarettes which feature packaging...more
5/31/2018
/ Child Safety ,
E-Cigarettes ,
Federal Trade Commission (FTC) ,
Food and Drug Administration (FDA) ,
FTC Act ,
Health and Safety ,
Manufacturers ,
Marketing ,
Misbranding ,
Popular ,
Retailers ,
Warning Letters